Literature DB >> 19650691

Heme scavenging and the other facets of hemopexin.

Emanuela Tolosano1, Sharmila Fagoonee, Noemi Morello, Francesca Vinchi, Veronica Fiorito.   

Abstract

Hemopexin is an acute-phase plasma glycoprotein, produced mainly by the liver and released into plasma, where it binds heme with high affinity. Other sites of hemopexin synthesis are the nervous system, skeletal muscle, retina, and kidney. The only known receptor for the heme-hemopexin complex is the scavenger receptor, LDL receptor-related protein (LRP)1, which is expressed in most cell types, thus indicating multiple sites of heme-hemopexin complex recovery. The better-characterized function of hemopexin is heme scavenging at the systemic level, consisting of the transport of heme to the liver, where it is catabolyzed or used for the synthesis of hemoproteins or exported to bile canaliculi. This is important both in physiologic heme management for heme-iron recycling and in pathologic conditions associated with intravascular hemolysis to prevent the prooxidant and proinflammatory effects of heme. Other than scavenging heme, the heme-hemopexin complex has been shown to be able to activate signaling pathways, thus promoting cell survival, and to modulate gene expression. In this review, the importance of heme scavenging by hemopexin, as well as the other emerging functions of this protein, are discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19650691     DOI: 10.1089/ars.2009.2787

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  105 in total

1.  Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.

Authors:  Sarah Millot; Constance Delaby; Boualem Moulouel; Thibaud Lefebvre; Nathalie Pilard; Nicolas Ducrot; Cécile Ged; Philippe Lettéron; Lucia de Franceschi; Jean Charles Deybach; Carole Beaumont; Laurent Gouya; Hubert De Verneuil; Saïd Lyoumi; Hervé Puy; Zoubida Karim
Journal:  Haematologica       Date:  2016-11-10       Impact factor: 9.941

2.  Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate.

Authors:  John D Belcher; Chunsheng Chen; Julia Nguyen; Ping Zhang; Fuad Abdulla; Phong Nguyen; Trevor Killeen; Pauline Xu; Gerry O'Sullivan; Karl A Nath; Gregory M Vercellotti
Journal:  Antioxid Redox Signal       Date:  2016-03-30       Impact factor: 8.401

3.  Inhaled nitric oxide attenuates the adverse effects of transfusing stored syngeneic erythrocytes in mice with endothelial dysfunction after hemorrhagic shock.

Authors:  Chong Lei; Binglan Yu; Mohd Shahid; Arkadi Beloiartsev; Kenneth D Bloch; Warren M Zapol
Journal:  Anesthesiology       Date:  2012-12       Impact factor: 7.892

Review 4.  Cell-free hemoglobin and its scavenger proteins: new disease models leading the way to targeted therapies.

Authors:  Dominik J Schaer; Paul W Buehler
Journal:  Cold Spring Harb Perspect Med       Date:  2013-06-01       Impact factor: 6.915

5.  Metal ions and electrolytes regulate the dissociation of heme from human hemopexin at physiological pH.

Authors:  Marcia R Mauk; A Grant Mauk
Journal:  J Biol Chem       Date:  2010-04-29       Impact factor: 5.157

6.  Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease.

Authors:  Stéphane M Camus; João A De Moraes; Philippe Bonnin; Paul Abbyad; Sylvain Le Jeune; François Lionnet; Laurent Loufrani; Linda Grimaud; Jean-Christophe Lambry; Dominique Charue; Laurent Kiger; Jean-Marie Renard; Claire Larroque; Hervé Le Clésiau; Alain Tedgui; Patrick Bruneval; Christina Barja-Fidalgo; Antigoni Alexandrou; Pierre-Louis Tharaux; Chantal M Boulanger; Olivier P Blanc-Brude
Journal:  Blood       Date:  2015-03-31       Impact factor: 22.113

7.  Hemopexin decreases hemin accumulation and catabolism by neural cells.

Authors:  Jing Chen-Roetling; Wenpei Liu; Raymond F Regan
Journal:  Neurochem Int       Date:  2012-02-07       Impact factor: 3.921

Review 8.  CD163 and inflammation: biological, diagnostic, and therapeutic aspects.

Authors:  Anders Etzerodt; Søren K Moestrup
Journal:  Antioxid Redox Signal       Date:  2012-10-19       Impact factor: 8.401

9.  Diamond Blackfan Anemia at the Crossroad between Ribosome Biogenesis and Heme Metabolism.

Authors:  Deborah Chiabrando; Emanuela Tolosano
Journal:  Adv Hematol       Date:  2010-05-05

Review 10.  Iron metabolism in the pathogenesis of iron-induced kidney injury.

Authors:  A M F Martines; R Masereeuw; H Tjalsma; J G Hoenderop; J F M Wetzels; D W Swinkels
Journal:  Nat Rev Nephrol       Date:  2013-05-14       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.